Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma, Large B-Cell, Diffuse 26Lymphoma 23Burkitt Lymphoma 22Multiple Myeloma 20Lymphoma, Non-Hodgkin 17Leukemia, Myeloid, Acute 16Lymphoma, Follicular 15Myelodysplastic Syndromes 14Lymphoma, Mantle-Cell 14Lymphoma, B-Cell 13Leukemia, Biphenotypic, Acute 13Lymphoma, T-Cell 9Hodgkin Disease 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Neuroblastoma 7Lymphoma, B-Cell, Marginal Zone 7Glioma 7Wilms Tumor 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Histiocytosis, Langerhans-Cell 6Hepatoblastoma 6Central Nervous System Neoplasms 6Rhabdoid Tumor 5Primary Myelofibrosis 5Osteosarcoma 5Neuroectodermal Tumors, Primitive, Peripheral 5Myeloproliferative Disorders 5Mycosis Fungoides 5

Interventions

Etoposide 6Vincristine 5Prednisone 5Doxorubicin 5Cyclophosphamide 5Rituximab 4prednylidene 3deltacortene 3daratumumab 2Cytarabine 2varlilumab 1pomalidomide 1merphos 1ixazomib 1carmustine, poliferprosan 20 drug combination 1belantamab mafodotin 1Vorinostat 1Specimen Handling 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Methotrexate 1Melphalan 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Hydrocortisone 1Disulfides 1Dexamethasone 1Carmustine 1CT-P10 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Plasmablastic Lymphoma × Specimen Handling × Lymphoid × Clear all
NCT07332507 2026-05-13

Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma

National Cancer Institute (NCI)

Phase 1 Not yet recruiting
30 enrolled
Lymphoid

Plasmablastic Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡